Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
The Tohoku Journal of Experimental Medicine|December 17, 2016
Meta-analysis Exploring the Effectiveness of S-1-Based Chemotherapy for Advanced Non-Small Cell Lung CancerXin Sun, Li Sun, Shu-Ling Zhang, et al.
Medicine|September 2, 2018
Efficacy and safety of apatinib in patients with advanced nonsmall cell lung cancer that failed prior chemotherapy or EGFR-TKIs: A pooled analysisJie-Tao Ma, Jing Sun, Li Sun, et al.
Molecular Medicine Reports|March 13, 2012
Altered expression of mitochondrial cytochrome c oxidase I and NADH dehydrogenase 4 transcripts associated with gastric tumorigenesis and tumor dedifferentiationJie-Tao Ma, Cheng-Bo Han, Yang Zhou, et al.
Translational Cancer Research|February 4, 2022
The influence of tumor heterogeneity on sensitivity of EGFR-mutant lung adenocarcinoma cells to EGFR-TKIsLi Sun, Yao-Yong Li, Jie-Tao Ma, et al.
World Journal of Gastroenterology|December 21, 2004
Quantitative analysis of tumor mitochondrial RNA using microarrayCheng-Bo Han, Xiao-Yun Mao, Yan Xin, et al.
Critical Reviews in Oncology/Hematology|July 17, 2025
Comparative efficacy of first-line therapies for PD-L1-negative advanced NSCLC: A network meta-analysis with reconstructed survival curvesJie-Tao Ma, Mei-Qi Yang, Shu-Ling Zhang, et al.
BMC Cancer|August 1, 2023
Rational application of EGFR-TKI adjuvant therapy in patients with completely resected stage IB-IIIA EGFR-mutant NSCLC: a systematic review and meta-analysis of 11 randomized controlled trialsShu-Ling Zhang, Xiao-Fang Yi, Le-Tian Huang, et al.
Translational Cancer Research|February 4, 2022
Impact of apatinib in combination with osimertinib on EGFR T790M-positive lung adenocarcinomaYang Liu, Zhi-Cheng Xiong, Xin Sun, et al.
Oncotargets and Therapy|May 9, 2017
Meta-analysis of the impact of de novo and acquired EGFR T790M mutations on the prognosis of patients with non-small cell lung cancer receiving EGFR-TKIsYang Liu, Li Sun, Zhi-Cheng Xiong, et al.
Cancer Letters|October 11, 2011
EGFR and KRAS mutations and altered c-Met gene copy numbers in primary non-small cell lung cancer and associated stage N2 lymph node-metastasisCheng-Bo Han, Jie-Tao Ma, Fan Li, et al.
Pageof 5